CIK 0000860730
- Large accelerated filer
HCA Healthcare, Inc.
Sign in to watch- Ticker
- HCA
- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 273865930
- Phone
- +1 615-344-9551
- Business address
- ONE PARK PLZ, NASHVILLE, TN, 37203
- Former names
- HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO, COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,251,400
- in 3 filings
Net −$18,251,400. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-10 | Cuffe Michael S. EVP and Chief Clinical Officer | Grant or award | +9,628 | 35,580.9 | ||
| 2026-02-10 | Cuffe Michael S. EVP and Chief Clinical Officer | Shares withheld for taxes | −3,501 | $502.05 | $1.8M | 32,079.9 |
| 2026-02-03 | Cuffe Michael S. EVP and Chief Clinical Officer | Sale | −1,500 | $498.09 | $747K | 30,002.9 |
| 2026-02-03 | Cuffe Michael S. EVP and Chief Clinical Officer | Gift | −4,050 | 25,952.9 | ||
| 2026-01-29 | Cuffe Michael S. EVP and Chief Clinical Officer | Grant or award · Stock Appreciation Right | +8,067 | 8,067 | ||
| 2025-09-08 | Cuffe Michael S. EVP and Chief Clinical Officer | Sale 10b5-1 | −3,836 | $418.84 | $1.6M | 31,502.9 |
| 2025-09-04 | Cuffe Michael S. EVP and Chief Clinical Officer | Option exercise 10b5-1 | +10,920 | $173.12 | $1.9M | 42,422.9 |
| 2025-09-04 | Cuffe Michael S. EVP and Chief Clinical Officer | Shares withheld for taxes 10b5-1 | −7,084 | $411.59 | $2.9M | 35,338.9 |
| 2025-09-04 | Cuffe Michael S. EVP and Chief Clinical Officer | Option exercise · Stock Appreciation Right 10b5-1 | −10,920 | 10,000 | ||
| 2025-02-13 | Cuffe Michael S. EVP and Chief Clinical Officer | Grant or award | +2,330 | 32,008.21 | ||
| 2025-02-13 | Cuffe Michael S. EVP and Chief Clinical Officer | Shares withheld for taxes | −583 | $321.92 | $188K | 31,425.21 |
| 2025-01-28 | Cuffe Michael S. EVP and Chief Clinical Officer | Grant or award · Stock Appreciation Right | +11,171 | 11,171 | ||
| 2024-09-12 | Cuffe Michael S. EVP and Chief Clinical Officer | Sale 10b5-1 | −8,358 | $385.42 | $3.2M | 29,678.21 |
| 2024-09-10 | Cuffe Michael S. EVP and Chief Clinical Officer | Option exercise 10b5-1 | +22,080 | $145.24 | $3.2M | 51,758.21 |
| 2024-09-10 | Cuffe Michael S. EVP and Chief Clinical Officer | Shares withheld for taxes 10b5-1 | −13,722 | $386.43 | $5.3M | 38,036.21 |
| 2024-09-10 | Cuffe Michael S. EVP and Chief Clinical Officer | Option exercise · Stock Appreciation Right 10b5-1 | −22,080 | 0 | ||
| 2024-05-09 | Cuffe Michael S. EVP and Chief Clinical Officer | Sale | −6,311 | $316.88 | $2.0M | 29,623.97 |
| 2024-05-08 | Cuffe Michael S. EVP and Chief Clinical Officer | Gift | −4,500 | 35,934.97 | ||
| 2024-05-07 | Cuffe Michael S. EVP and Chief Clinical Officer | Option exercise | +18,660 | $139.06 | $2.6M | 52,783.97 |
| 2024-05-07 | Cuffe Michael S. EVP and Chief Clinical Officer | Shares withheld for taxes | −12,349 | $314.45 | $3.9M | 40,434.97 |
Page 1 of 5 · 86 trades